These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 27568322)

  • 21. Ramucirumab in HER-2-positive gastroesophageal adenocarcinoma: an argument for overcoming trastuzumab resistance.
    Tehfe M; Tabchi S; Laterza MM; De Vita F
    Future Oncol; 2018 Feb; 14(3):223-228. PubMed ID: 29318901
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The safety and efficacy of ramucirumab in combination with paclitaxel for the treatment of advanced gastric or gastro-esophageal junction adenocarcinoma.
    Garrido M
    Expert Rev Anticancer Ther; 2016 Oct; 16(10):1005-10. PubMed ID: 27582051
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Update on Gastroesophageal Adenocarcinoma Targeted Therapies.
    Maron SB; Catenacci DVT
    Hematol Oncol Clin North Am; 2017 Jun; 31(3):511-527. PubMed ID: 28501091
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of short-term effectiveness of eight targeted agents combined with chemotherapy for treating esophageal-gastric junction adenocarcinoma: A network meta-analysis.
    He YM; Yu C; Li WB; Li ZP; Xu N
    J Cell Biochem; 2018 Jan; 119(1):1183-1192. PubMed ID: 28708307
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multicenter phase II study of irinotecan, cisplatin, and bevacizumab in patients with metastatic gastric or gastroesophageal junction adenocarcinoma.
    Shah MA; Ramanathan RK; Ilson DH; Levnor A; D'Adamo D; O'Reilly E; Tse A; Trocola R; Schwartz L; Capanu M; Schwartz GK; Kelsen DP
    J Clin Oncol; 2006 Nov; 24(33):5201-6. PubMed ID: 17114652
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pembrolizumab for treatment of advanced gastric and gastroesophageal junction adenocarcinoma.
    Joshi SS; Maron SB; Catenacci DV
    Future Oncol; 2018 Feb; 14(5):417-430. PubMed ID: 29094609
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinicopathologic features and treatment outcomes of patients with human epidermal growth factor receptor 2-positive adenocarcinoma of the esophagus and gastroesophageal junction.
    Phillips BE; Tubbs RR; Rice TW; Rybicki LA; Plesec T; Rodriguez CP; Videtic GM; Saxton JP; Ives DI; Adelstein DJ
    Dis Esophagus; 2013 Apr; 26(3):299-304. PubMed ID: 22676551
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Systemic therapy for esophagogastric cancer: targeted therapies.
    Lyons TG; Ku GY
    Chin Clin Oncol; 2017 Oct; 6(5):48. PubMed ID: 29129088
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeted Treatment of Esophagogastric Cancer.
    Kopp HG; Hofheinz RD
    Oncol Res Treat; 2016; 39(12):788-794. PubMed ID: 27889780
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeted therapy for gastric cancer--current status.
    Kulig J; Kołodziejczyk P; Kulig P; Legutko J
    J Oncol Pharm Pract; 2013 Mar; 19(1):75-81. PubMed ID: 22711713
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Update on metastatic gastric and esophageal cancers.
    Shah MA
    J Clin Oncol; 2015 Jun; 33(16):1760-9. PubMed ID: 25918288
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Palliative chemotherapy for gastroesophageal cancer in old and very old patients: A retrospective cohort study at the National Center for Tumor Diseases, Heidelberg.
    Berger AK; Zschaebitz S; Komander C; Jäger D; Haag GM
    World J Gastroenterol; 2015 Apr; 21(16):4911-8. PubMed ID: 25945004
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ramucirumab: first global approval.
    Poole RM; Vaidya A
    Drugs; 2014 Jun; 74(9):1047-58. PubMed ID: 24916147
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targetting esophageal and gastric cancers with monoclonal antibodies.
    Norguet E; Dahan L; Seitz JF
    Curr Top Med Chem; 2012; 12(15):1678-82. PubMed ID: 22978338
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Irinotecan/cisplatin in advanced, treated gastric or gastroesophageal junction carcinoma.
    Ajani JA; Baker J; Pisters PW; Ho L; Mansfield PF; Feig BW; Charnsangavej C
    Oncology (Williston Park); 2002 May; 16(5 Suppl 5):16-8. PubMed ID: 12109800
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative efficacy of treatments for previously treated patients with advanced esophageal and esophagogastric junction cancer: A network meta-analysis.
    Lin S; Liu T; Chen J; Li G; Dang J
    PLoS One; 2021; 16(6):e0252751. PubMed ID: 34086780
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Trastuzumab for the treatment of HER2-positive metastatic adenocarcinoma of the stomach or gastro-oesophageal junction.
    Norman G; Rice S; Spackman E; Stirk L; Danso-Appiah A; Suh D; Palmer S; Eastwood A
    Health Technol Assess; 2011 May; 15 Suppl 1():33-42. PubMed ID: 21609651
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phase II study of the antibody-drug conjugate TAK-264 (MLN0264) in patients with metastatic or recurrent adenocarcinoma of the stomach or gastroesophageal junction expressing guanylyl cyclase C.
    Almhanna K; Miron ML; Wright D; Gracian AC; Hubner RA; Van Laethem JL; López CM; Alsina M; Muñoz FL; Bendell J; Firdaus I; Messersmith W; Ye Z; Fasanmade AA; Danaee H; Kalebic T
    Invest New Drugs; 2017 Apr; 35(2):235-241. PubMed ID: 28188407
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ramucirumab for metastatic gastric or gastroesophageal junction cancer: results and implications of the REGARD trial.
    Liguigli W; Tomasello G; Toppo L; Ratti M; Passalacqua R
    Future Oncol; 2014; 10(9):1549-57. PubMed ID: 25145426
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Panitumumab added to docetaxel, cisplatin and fluoropyrimidine in oesophagogastric cancer: ATTAX3 phase II trial.
    Tebbutt NC; Price TJ; Ferraro DA; Wong N; Veillard AS; Hall M; Sjoquist KM; Pavlakis N; Strickland A; Varma SC; Cooray P; Young R; Underhill C; Shannon JA; Ganju V; Gebski V
    Br J Cancer; 2016 Mar; 114(5):505-9. PubMed ID: 26867157
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.